Recent research focusing on Retatrutide at a dosage of 40mg is shedding new light on its potential benefits. Preliminary findings suggest that this higher dosage may boost the drug's ability to regulate blood sugar, potentially offering greater outcomes for individuals with insulin resistance. Further investigation is underway to fully explore the